Novartis Buys License to AlphaVax’s Cytomegalovirus Vaccine
Bloomberg - Dec 28, 2008
29 (Bloomberg) — Novartis AG said it bought rights to AlphaVax Inc.’s experimental cytomegalovirus vaccine, paying million for a shot that may prevent …
Novartis acquires license to CMV vaccine candidate The Associated Press
Alphavax, Novartis team on herpes vaccine News & Observer
Novartis Paying M Up Front for AlphaVax's CMV Candidate BioWorld Online
SmartBrief - Reuters UK
all 139 news articles